Goldberg, Matthew S, Jennifer J Siegel, Kelli Ahmed, Sarah J Kurley, and Aaron S Farberg. “A Prospective Clinical Utility Study Demonstrates That Physicians Use the 40-Gene Expression Profile (40-GEP) to Guide Clinical Management Decisions for Medicare-Eligible Patients With Cutaneous Squamous Cell Carcinoma (cSCC)”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s95. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/1854.